Post-vaccination serum cytokines levels correlate with breakthrough influenza infections

[1]  W. Lau,et al.  Influenza vaccination reveals sex dimorphic imprints of prior mild COVID-19 , 2023, Nature.

[2]  B. Pulendran,et al.  Pan-vaccine analysis reveals innate immune endotypes predictive of antibody responses to vaccination , 2022, Nature immunology.

[3]  N. Goplen,et al.  Immune determinants of chronic sequelae after respiratory viral infection , 2022, Science Immunology.

[4]  K. Khunti,et al.  Associations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: a population-based cohort study , 2022, The Lancet Diabetes & Endocrinology.

[5]  D. Metzger,et al.  Viral PB1-F2 and host IFN-γ guide ILC2 and T cell activity during influenza virus infection , 2022, Proceedings of the National Academy of Sciences.

[6]  Rodney P. Jones,et al.  Trends in Excess Winter Mortality (EWM) from 1900/01 to 2019/20—Evidence for a Complex System of Multiple Long-Term Trends , 2022, International journal of environmental research and public health.

[7]  C. Deutschman,et al.  Obesity and Metabolic Dysregulation in Children Provide Protective Influenza Vaccine Responses , 2022, Viruses.

[8]  J. Tregoning,et al.  Prior upregulation of interferon pathways in the nasopharynx impacts viral shedding following live attenuated influenza vaccine challenge in children , 2021, Cell reports. Medicine.

[9]  P. Aaby,et al.  Oral Polio Vaccine Campaigns May Reduce the Risk of Death from Respiratory Infections , 2021, Vaccines.

[10]  M. Netea,et al.  Induction of trained immunity by influenza vaccination - impact on COVID-19 , 2021, medRxiv.

[11]  Diane J Post,et al.  A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future. , 2021, Vaccine.

[12]  M. Dimopoulos,et al.  Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients , 2021, Cell Reports.

[13]  J. M. Eirós-Bouza,et al.  Do Vaccines Need a Gender Perspective? Influenza Says Yes! , 2021, Frontiers in Immunology.

[14]  M. Zand,et al.  Impaired HA-specific T follicular helper cell and antibody responses to influenza vaccination are linked to inflammation in humans. , 2021, medRxiv.

[15]  C. Takahashi,et al.  The effect of partially hydrolyzed guar gum on preventing influenza infection. , 2021, Clinical nutrition ESPEN.

[16]  D. Beezhold,et al.  Differential Expression of Serum Exosome microRNAs and Cytokines in Influenza A and B Patients Collected in the 2016 and 2017 Influenza Seasons , 2021, Pathogens.

[17]  K. Walters,et al.  Sex Differences in Influenza: The Challenge Study Experience. , 2021, The Journal of infectious diseases.

[18]  Steven H Kleinstein,et al.  Human germinal centres engage memory and naïve B cells after influenza vaccination , 2020, Nature.

[19]  P. Aaby,et al.  Vaccinology: time to change the paradigm? , 2020, The Lancet. Infectious diseases.

[20]  R. Cox,et al.  Meeting report and review: Immunological assays and correlates of protection for next‐generation influenza vaccines , 2019, Influenza and other respiratory viruses.

[21]  R. A. van den Berg,et al.  Characterization of potential biomarkers of reactogenicity of licensed antiviral vaccines: randomized controlled clinical trials conducted by the BIOVACSAFE consortium , 2019, Scientific Reports.

[22]  H. Maecker,et al.  Diminished B-Cell Response After Repeat Influenza Vaccination , 2018, The Journal of infectious diseases.

[23]  D. Faix,et al.  Seasonal Influenza Vaccine Impact on Pandemic H1N1 Vaccine Efficacy , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  J. Alcorn,et al.  Inflammatory Mediator Expression Associated With Antibody Response Induced by Live Attenuated vs Inactivated Influenza Virus Vaccine in Children , 2018, Open forum infectious diseases.

[25]  E. Sanders,et al.  Robust Humoral and Cellular Immune Responses to Pertussis in Adults After a First Acellular Booster Vaccination , 2018, Front. Immunol..

[26]  N. Halsey,et al.  Rapid changes in serum cytokines and chemokines in response to inactivated influenza vaccination , 2018, Influenza and other respiratory viruses.

[27]  R. Cox,et al.  Immune responses after live attenuated influenza vaccination , 2018, Human vaccines & immunotherapeutics.

[28]  Michael T. Zimmermann,et al.  Transcriptomic signatures of cellular and humoral immune responses in older adults after seasonal influenza vaccination identified by data-driven clustering , 2018, Scientific Reports.

[29]  Hang Xie,et al.  Different Repeat Annual Influenza Vaccinations Improve the Antibody Response to Drifted Influenza Strains , 2017, Scientific Reports.

[30]  J. Tregoning,et al.  Inflammatory responses to influenza vaccination at the extremes of age , 2017, Immunology.

[31]  M. Hudgens,et al.  Increased risk of influenza among vaccinated adults who are obese , 2017, International Journal of Obesity.

[32]  V. Aravindhan,et al.  Long term persistence of inflammation in children vaccinated with Salmonella conjugate vaccine is associated with augmented Th9‐Th17 cytokine , 2017, Cytokine.

[33]  D. Díaz-Arévalo,et al.  A dual purpose universal influenza vaccine candidate confers protective immunity against anthrax , 2017, Immunology.

[34]  X. de Lamballerie,et al.  Immunity against influenza A(H1N1) infections is determined by age at the time of initial strain circulation , 2016, Epidemiology and Infection.

[35]  Yongchao Ge,et al.  Perfluoroalkyl substance serum concentrations and immune response to FluMist vaccination among healthy adults. , 2016, Environmental research.

[36]  C. Peteranderl,et al.  Human Influenza Virus Infections , 2016, Seminars in Respiratory and Critical Care Medicine.

[37]  J. James,et al.  Unique Inflammatory Mediators and Specific IgE Levels Distinguish Local from Systemic Reactions after Anthrax Vaccine Adsorbed Vaccination , 2016, Clinical and Vaccine Immunology.

[38]  B. C. Haynes,et al.  Correlates of Immunity to Influenza as Determined by Challenge of Children with Live, Attenuated Influenza Vaccine , 2016, Open forum infectious diseases.

[39]  K. Subbarao,et al.  Live attenuated influenza vaccine. , 2020, Current topics in microbiology and immunology.

[40]  Christopher L. Perdue,et al.  A Brief Description of the Operation of the DoD Serum Repository. , 2015, Military medicine.

[41]  Andrew Platt,et al.  Innate immunity and vaccines. , 2013, Current topics in medicinal chemistry.

[42]  Xiaowen Jiang,et al.  CD4 T-helper cell cytokine phenotypes and antibody response following tetanus toxoid booster immunization. , 2013, Journal of immunological methods.

[43]  Yongchao Ge,et al.  Localized mucosal response to intranasal live attenuated influenza vaccine in adults. , 2013, The Journal of infectious diseases.

[44]  J. Bream,et al.  Differential serum cytokine responses to inactivated and live attenuated seasonal influenza vaccines. , 2012, Cytokine.

[45]  Jen-Ren Wang,et al.  The regulatory T cells in anti-influenza antibody response post influenza vaccination , 2012, Human vaccines & immunotherapeutics.

[46]  M. Chen,et al.  Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers. , 2012, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[47]  GS Goldman,et al.  Relative trends in hospitalizations and mortality among infants by the number of vaccine doses and age, based on the Vaccine Adverse Event Reporting System (VAERS), 1990–2010 , 2012, Human & experimental toxicology.

[48]  M. Curran,et al.  Live Attenuated Influenza Vaccine (FluMist®; Fluenz™) , 2011, Drugs.

[49]  Richard K. Zimmerman,et al.  Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza in Pittsburgh, PA, USA , 2010, PloS one.

[50]  Brendan Giles,et al.  Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza , 2010, PLoS currents.

[51]  Libo Dong,et al.  Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. , 2009, The New England journal of medicine.

[52]  Ron A M Fouchier,et al.  Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans , 2009, Science.

[53]  T. Fry,et al.  Cytokines as Adjuvants for Vaccine and Cellular Therapies for Cancer. , 2009, American journal of immunology.

[54]  Julie A. Pavlin,et al.  Code-based Syndromic Surveillance for Influenzalike Illness by International Classification of Diseases, Ninth Revision , 2007, Emerging infectious diseases.

[55]  S. Rijpkema,et al.  Investigation in a Model System of the Effects of Combinations of Anthrax and Pertussis Vaccines Administered to Service Personnel in the 1991Gulf War , 2005, Human vaccines.

[56]  H. Maecker,et al.  TNF-α detection using a flow cytometric assay to determine cellular responses to anthrax vaccine , 2003 .

[57]  H. Maecker,et al.  TNF-alpha detection using a flow cytometric assay to determine cellular responses to anthrax vaccine. , 2003, Journal of immunological methods.

[58]  Carlo Russo,et al.  SERUM CYTOKINE LEVELS AND ANTIBODY RESPONSE TO INFLUENZA VACCINE IN THE ELDERLY , 2001, Immunopharmacology and immunotoxicology.

[59]  A S Perelson,et al.  Variable efficacy of repeated annual influenza vaccination. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[60]  S. Kardong-Edgren.  Is it time to change the paradigm? , 1999, Journal of obstetric, gynecologic, and neonatal nursing : JOGNN.

[61]  R. Rubin,et al.  Cytokines as potential vaccine adjuvants , 1994, Biotherapy.